Previous 10 | Next 10 |
KORU Medical Systems (KRMD) Q1 2021 Earnings Conference Call May 12, 2021 04:30 PM ET Company Participants Greg Chodaczek - Investor Relations Linda Tharby - President and Chief Executive Officer Karen Fisher - Chief Financial Officer Conference Call Participants Alex Nowak - Craig-Hallum Cap...
Repro Med Systems (KRMD): Q1 Non-GAAP EPS of $0.00 beats by $0.01; GAAP EPS of -$0.03 misses by $0.02.Revenue of $5.43M (-14.2% Y/Y) beats by $0.33M.Press Release For further details see: Repro Med Systems EPS beats by $0.01, beats on revenue
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of...
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solut...
Repro Med Systems Inc. (NASDAQ:KRMD) traded today at a new 52-week low of $2.72. So far today approximately 272,000 shares have been exchanged, as compared to an average 30-day volume of 289,000 shares. Repro Med Systems Inc. has overhead space with shares priced $2.80, or 18.1% below th...
Repro Med Systems Inc. (NASDAQ:KRMD) traded today at a new 52-week low of $3.16. This new low was reached on approximately average trading volume as 272,000 shares traded hands, while the average 30-day volume is approximately 289,000 shares. Repro Med Systems Inc. has overhead space wit...
NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Repro Med Systems, Inc. (“Repro Med”) (NASDAQ: KRMD) in the United States District Court for the Southern District of New York on behalf of t...
Repro Med Systems, Inc. (KRMD) Q4 2020 Results Conference Call March 23, 2021 04:30 PM ET Company Participants Greg Chodaczek - Senior Vice President, The Equity Group, Inc. Jim Beck - Interim CEO Linda Tharby - President & Chief Executive Officer Karen Fisher - Chief Financial Officer Co...
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company") a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of ...
Repro Med Systems, doing business as KORU Medical Systems, (KRMD) announces that Linda Tharby has been appointed President and Chief Executive Officer and will succeed Interim CEO Jim Beck effective April 12, 2021.Tharby, is an experienced global medical device i...
News, Short Squeeze, Breakout and More Instantly...
KORU Medical Systems Inc. Company Name:
KRMD Stock Symbol:
NYSE Market:
KORU Medical Systems Inc. Website:
2024-07-02 12:15:04 ET Canaccord Genuity analyst issues BUY recommendation for KRMD on July 2, 2024 10:05AM ET. The previous analyst recommendation was Buy. KRMD was trading at $2.25 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current...
2024-07-02 12:00:07 ET Kyle Rose from Canaccord Genuity issued a price target of $3.00 for KRMD on 2024-07-02 10:05:00. The adjusted price target was set to $3.00. At the time of the announcement, KRMD was trading at $2.25. The overall price target consensus is at $4.50 ...
KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announ...